Abstract
Epstein-Barr virus (EBV) is able to override the mechanisms that normally regulate the proliferation of human B-lymphocytes. In the absence of other extracellular signals, EBV infects resting B-lymphocytes and drives the infected cells into the cell-division cycle. Recently, there has been much interest in defining the molecular mechanisms by which EBV reprograms the cell cycle control machinery in B-lympho-cytes (1–19).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sinclair, A. J., Palmero, I., Peters, G., and Farrell, P. J. (1994) EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J. 13, 3321–3328.
Sinclair, A. J. and Farrell, P. J. (1995) Methods to study Epstein-Barr virus and p53 status in human cells, in Methods in Molecular Genetics 7, Academic Press, Orlando, FL, pp. 89–100.
Sinclair, A. J. and Farrell, P. J. (1995) Host cell requirements for efficient infection of quiescent primary B-lymphocytes by Epstein-Barr virus. J. Virol. 69, 5461–5468.
Sinclair, A. J., Palmero, I., Holder, A., Peters, G., and Farrell, P. J. (1995) Expression of cyclin D2 in EBV positive Burkitt’s lymphoma cell lines is related to methylation status of the gene. J. Virol. 69, 1292–1295.
Allday, M. J., Sinclair, A. J., Parker, G., Crawford, D. H., and Farrell, P. J. (1995) Epstein-Barr virus efficiently immortalises human B cells without neutralising the function of p53. EMBO J. 14, 1382–1391.
Allday, M. J., Inman, G. J., Crawford, D. H., and Farrell, P. J. (1995) DNA-damage in human B-cells can induce apoptosis, proceeding from G(1)/S when p53 is transactivation competent and G(2)/M when it is transactivation defective. EMBO J. 14, 4994–5005.
Cannell, E. J., Farrell, P. J., and Sinclair, A. J. (1996) Epstein-Barr-virus exploits the normal-cell pathway to regulate Rb activity during the immortalization of primary B-cells. Oncogene 13, 1413–1421.
Hollyoake, M., Stuhler, A., Farrell, P., Gordon, J., and Sinclair, A. (1995) The normal-cell cycle activation program is exploited during the infection of quiescent B-lymphocytes by Epstein-Barr-virus. Cancer Res. 55, 4784–4787.
Palmero, I., Holder, A., Sinclair, A. J., Dickson, C., and Peters, G. (1993) Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines. Oncogene 8, 1049–1054.
Cayrol, C. and Flemington, E. (1996) G(0)/G(1) growth arrest mediated by a region encompassing the basic leucine-zipper (bzip) domain of the Epstein-Barr-virus transactivator zta. J. Biol. Chem. 271, 31,799–31,802.
Cayrol, C. and Flemington, E. K. (1996) The Epstein-Barr-virus bZip transcription factor Zta causes G(0)/G(1) cell-cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J. 15, 2748–2759.
Chen, W. and Cooper, N. R. (1996) Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-κB activity. J. Virol. 70, 4849–4853.
Floettmann, J. E., Ward, K., Rickinson, A. B., and Rowe, M. (1996) Cytostatic effect of Epstein-Barr-virus latent membrane protein-1 analysed using tetracycline-regulated expression in B-cell lines. Virology 223, 29–40.
Jiang, W. Q., Szekely, L., Wendel-Hansen, V., Ringertz, N., and Klein, G. (1991) Co-localisation of the retinoblastoma protein and the Epstein-Barr virus encoded nuclear antigen EBNA-5. Exp. Cell Res. 197, 41–51.
Kempkes, B., Spitkovsky, D., Jansendurr, P., Ellwart, J. W., Kremmer, E., Delecluse, H. J., et al. (1995) B-cell proliferation and induction of early G(1)-regulating proteins by Epstein-Barr-virus mutants conditional for EBNA2. EMBO J. 14, 88–96.
Kitay, M. K. and Rowe, D. T. (1996) Protein-protein interactions between Epstein-Barr virus nuclear antigen-LP and cellular gene products: binding of 70kD heat shock proteins. Virology 220, 91–99.
Kitay, M. K. and Rowe, D. T. (1996) Cell-cycle stage-specific phosphorylation of the Epstein-Barr-virus immortalization protein EBNA-LP. J. Virol. 70, 7885–7893.
Szekely, L., Pokrovskaja, K., Jiang, W. Q., Selivanova, G., Lowbeer, M., Ringertz, N., et al. (1995) Resting B-cells, EBV infected B-blasts and established lymphoblastoid cell lines differ in their pRb, p53 and EBNA-5 expression patterns. Oncogene 10, 1869–1874.
Szekely, L., Selivanova, G., Magnusson, K. P., Klein, G., and Winman, K. G. (1993) EBNA-5, an Epstein-Barr virus encoded nuclear antigen binds to the retinoblastoma and p53 proteins. Proc. Natl. Acad. Sci. USA 90, 5455–5459.
Omerod, M. G. (1994) Flow Cytometry. BIOS Scientific Publishers, Oxford.
Robinson, J. P. (1993) Handbook of Flow Cytometric Methods. Wiley-Liss, Inc., New York, NY.
Gratzner, H. G. (1982) Monoclonal-antibody to 5-bromodeoxyuridine and 5-iododeoxy-uridine: a new reagent for detection of DNA-replication. Science 218, 474–475.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Sinclair, A.J. (2001). Cell Cycle Distribution of B-Lymphocytes and Cell Lines. In: Wilson, J.B., May, G.H.W. (eds) Epstein-Barr Virus Protocols. Methods in Molecular Biology™, vol 174. Humana Press. https://doi.org/10.1385/1-59259-227-9:129
Download citation
DOI: https://doi.org/10.1385/1-59259-227-9:129
Publisher Name: Humana Press
Print ISBN: 978-0-89603-690-1
Online ISBN: 978-1-59259-227-2
eBook Packages: Springer Protocols